The CDC’s National Center for Health Statistics published a data brief in February 2024 that provides data on HPV vaccination coverage in U.S. youth aged 9-17. The HPV vaccine prevents the sexually transmitted infection of human papillomavirus, which causes nearly all cervical cancer as well as most oropharyngeal (throat/mouth), anal, penile, vaginal, and vulvar cancer. Coverage remains well below targets at 38.6% across all age groups but over half of 15-17-year-olds (56.9%). Black and white youth have the highest coverage rates with Asian and Hispanic youth lagging 5 to 6 percentage points behind.
